Serious Adverse Events and Laboratory Monitoring Regimens for Outpatient Parenteral Antimicrobial Therapy With Cefazolin and Ceftriaxone

Shawnalyn W Sunagawa, Sarah Arduser, Molly M Miller, Elizabeth Lyden, Melissa LeMaster, Nicolas Cortes-Penfield, Richard J Hankins, Scott J Bergman, Bryan T Alexander · 2023

Read Serious Adverse Events and Laboratory Monitoring Regimens for Outpatient Parenteral Antimicrobial Therapy With Cefazolin and Ceftriaxone by Shawnalyn W Sunagawa, Sarah Arduser, Molly M Miller, Elizabeth Lyden, Melissa LeMaster, Nicolas Cortes-Penfield, Richard J Hankins, Scott J Bergman, Bryan T Alexander (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10727193.txt.

Description

Shawnalyn Sunagawa and co-authors review safety monitoring for home infusion antibiotics in a 2023 study. Patients on outpatient intravenous cefazolin or ceftriaxone usually give blood weekly to catch side effects early. Counting serious therapy-linked events in their cohort, the team found only 2.7 events per thousand weekly lab sets. So little yield from weekly draws suggests a lighter testing schedule could be safe and reasonable for these two drugs, cutting patient burden and cost.

Catalog record

CREATORShawnalyn W Sunagawa, Sarah Arduser, Molly M Miller, Elizabeth Lyden, Melissa LeMaster, Nicolas Cortes-Penfield, Richard J Hankins, Scott J Bergman, Bryan T Alexander
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10727193

Browse the full library · About the Tower of Babel